---
figid: PMC7963155__cancers-13-01168-g004a
figtitle: MicroRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7963155
filename: cancers-13-01168-g004a.jpg
figlink: .na.character
number: F4a
caption: miRNA-lncRNAs regulatory loops determine cisplatin resistance in cervical
  cancer. In cisplatin-sensitive cells (blue rectangles) GAS5 or CASC2 lncRNAs sponge
  miR-21, thus PTEN dephosphorylates PIP3 into PI2, preventing AKT pathway activation,
  resulting in reduced proliferation, drug resistance, and increased cell apoptosis
  (A). In resistant cells (red rectangle), the downregulation of GAS5 and CASC2 cause
  the PTEN inhibition by miR-21 determining the PI3K/AKT pathway activation (B). MiR-21
  can also contribute to the repression of the two lncRNAs (A,B). In cisplatin-resistant
  cells (red rectangle), the sponging of miR-134-5p by NCK1-AS1 leads to MSH2, ABCB1,
  and Bcl-2 up-regulation determining drug resistance and cell survival (D). In cisplatin-sensitive
  cells (blue rectangle), the downregulation of the lncRNA NCK1-AS1 determines the
  inhibition of MSH2 by miR-134-5p, associated with a decrease of ABCB1 and Bcl-2
  to promote cisplatin-induced cell death (C).
papertitle: The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical
  Cancer.
reftext: Rina Masadah, et al. Cancers (Basel). 2021 Mar;13(5):1168.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9690643
figid_alias: PMC7963155__F4a
figtype: Figure
redirect_from: /figures/PMC7963155__F4a
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7963155__cancers-13-01168-g004a.html
  '@type': Dataset
  description: miRNA-lncRNAs regulatory loops determine cisplatin resistance in cervical
    cancer. In cisplatin-sensitive cells (blue rectangles) GAS5 or CASC2 lncRNAs sponge
    miR-21, thus PTEN dephosphorylates PIP3 into PI2, preventing AKT pathway activation,
    resulting in reduced proliferation, drug resistance, and increased cell apoptosis
    (A). In resistant cells (red rectangle), the downregulation of GAS5 and CASC2
    cause the PTEN inhibition by miR-21 determining the PI3K/AKT pathway activation
    (B). MiR-21 can also contribute to the repression of the two lncRNAs (A,B). In
    cisplatin-resistant cells (red rectangle), the sponging of miR-134-5p by NCK1-AS1
    leads to MSH2, ABCB1, and Bcl-2 up-regulation determining drug resistance and
    cell survival (D). In cisplatin-sensitive cells (blue rectangle), the downregulation
    of the lncRNA NCK1-AS1 determines the inhibition of MSH2 by miR-134-5p, associated
    with a decrease of ABCB1 and Bcl-2 to promote cisplatin-induced cell death (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GAS5
  - MIR21
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CASC2
  - Cisplatin
  - cancer
---
